Literature DB >> 8625977

Increase of intracellular calcium is the essential signal for the expression of CD40 ligand.

H G Nüsslein1, K H Frosch, W Woith, P Lane, J R Kalden, B Manger.   

Abstract

CD40 ligand (CD40L) is present on activated but not on resting T cells. In contrast to the activation markers CD25 and CD71, a strong CD40L expression could be induced by calcium ionophore alone but not by phorbol 12-myristate 13-acetate (PMA). Ionomycin induced a very early mRNA and protein surface expression of CD40L within the first 2 h, whereas CD25 and CD71 did not appear earlier than 6 h after stimulation. The mitogens phytohemagglutinin and concanavalin A induced little CD40L, but together with PMA, a markedly increased CD40L expression was observed. In T cells stimulated with immobilized anti-CD3, co-stimulation with anti-CD28 or PMA induced an earlier and higher maximal CD40L expression. CD40L expression of purified T cells was higher and more prolonged compared to that of T cells in unseparated peripheral blood mononuclear cells. We conclude that the expression of CD40L on T cells is profoundly different from other early activation markers with regard to signal requirements, kinetics and the role of accessory cells in the system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625977     DOI: 10.1002/eji.1830260418

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells.

Authors:  Thitirat Ngaotepprutaram; Barbara L F Kaplan; Norbert E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2013-08-30       Impact factor: 4.219

2.  Endothelial cell and cAMP regulation of T-cell CD40 ligand: relevance of calcium/calmodulin-dependent kinase IV signalling.

Authors:  Christopher P Nielson; Denise Wingett
Journal:  Immunology       Date:  2002-04       Impact factor: 7.397

Review 3.  Immune cell signaling aberrations in human lupus.

Authors:  S N Liossis; P P Sfikakis; G C Tsokos
Journal:  Immunol Res       Date:  1998-08       Impact factor: 2.829

4.  NF-kappaB is involved in regulation of CD40 ligand expression on Mycobacterium bovis bacillus Calmette-Guérin-activated human T cells.

Authors:  Patricia Méndez-Samperio; Hilda Ayala; Abraham Vázquez
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

5.  Irradiation up-regulates CD80 expression through induction of tumour necrosis factor-alpha and CD40 ligand expression on B lymphoma cells.

Authors:  Fumio Ishikawa; Hideki Nakano; Akira Seo; Yayoi Okada; Hideko Torihata; Yuriko Tanaka; Tetsuya Uchida; Hidekazu Miyake; Terutaka Kakiuchi
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

Review 6.  Post-transcriptional regulation in lymphocytes: the case of CD154.

Authors:  Stefano Vavassori; Lori R Covey
Journal:  RNA Biol       Date:  2009-07-29       Impact factor: 4.652

7.  Functional analysis of a tripartite stability element within the CD40 ligand 3' untranslated region.

Authors:  Jennifer Laughlin; Sanaz Oghlidos; Joseph F Porter; Rodrigo Matus-Nicodemos; Frank L Sinquett; Valentina Marcelli; Lori R Covey
Journal:  Immunology       Date:  2008-01-11       Impact factor: 7.397

8.  Delineation of a novel pathway that regulates CD154 (CD40 ligand) expression.

Authors:  B JoNell Hamilton; Anna Genin; Randy Q Cron; William F C Rigby
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

9.  Differential modulation by delta9-tetrahydrocannabinol (∆9)-THC) of CD40 ligand (CD40L) expression in activated mouse splenic CD4+ T cells.

Authors:  Thitirat Ngaotepprutaram; Barbara L F Kaplan; Robert B Crawford; Norbert E Kaminski
Journal:  J Neuroimmune Pharmacol       Date:  2012-08-01       Impact factor: 4.147

10.  Orally tolerant CD4 T cells respond poorly to antigenic stimulation but strongly to direct stimulation of intracellular signaling pathways.

Authors:  K Asai; S Hachimura; T Toraya; S Kaminogawa
Journal:  Cytotechnology       Date:  2001-07       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.